Medistim ASA (LTS:0OCD) Growth Rank: 10 (As of Sep. 18, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0OCD Medistim ASA LTS:0OCD
99 GF Score
Price kr244.00
GF Value kr264.73
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Medistim ASA Growth Rank?

Medistim ASA LTS:0OCD -0.41% 99 Growth Rank is 10 as of Sep. 18, 2026, which is at its 10-year median of 10.00. GuruFocus rates LTS:0OCD with a GF Score™ of 99/100 and a GF Value™ of kr264.73 (Fairly Valued). The stock has 4 warning signs investors should review.

Medistim ASA has the Growth Rank of 10.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

LTS:0OCD vs ABT, SYK, MDT: Growth Rank Comparison

For the Medical Devices subindustry, Medistim ASA's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medistim ASA Growth Rank vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's Growth Rank distribution charts can be found below:

* The bar in red indicates where Medistim ASA's Growth Rank falls into.


LTS:0OCD
99GF Score
Medistim ASA LTS:0OCD
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 10 mean?
Medistim ASA (LTS:0OCD) has a Growth Rank of 10 as of Sep. 18, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Medistim ASA and its competitors. This is near median its historical median of 10.00. Over the past decade, Medistim ASA's Growth Rank has ranged from 3.00 to 10.00.
Is Medistim ASA's Growth Rank too high?
Medistim ASA's current Growth Rank of 10 is near median its 10-year median of 10.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 10.00. Overall, Medistim ASA has a GF Score™ of 99/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medistim ASA's Growth Rank compare to ABT and SYK?
Medistim ASA's Growth Rank of 10 can be compared against companies in the Medical Devices & Instruments industry. Historically, Medistim ASA's own Growth Rank has ranged from 3.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Devices & Instruments company?
A good Growth Rank depends on the Medical Devices & Instruments industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Medistim ASA and its competitors. Medistim ASA's current Growth Rank is 10, which is near median its own 10-year median of 10.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistim ASA stock overvalued right now?
Based on GuruFocus' analysis, Medistim ASA (LTS:0OCD) is currently considered Fairly Valued. The stock's GF Value™ is kr264.73, compared to a current price of kr244.00 — trading 7.8% below its estimated fair value. The current Growth Rank is 10, which is near median its 10-year median of 10.00. Medistim ASA's overall GF Score™ is 99/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Medistim ASA (LTS:0OCD), the current Growth Rank is 10 as of Sep. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medistim ASA (LTS:0OCD) Overvalued in 2026?

Based on GuruFocus' analysis, Medistim ASA stock appears to be undervalued. The current stock price of kr244.00 is trading 7.8% below its estimated GF Value™ of kr264.73. GuruFocus considers Medistim ASA to be Fairly Valued.

Key valuation signals for LTS:0OCD:

  • Growth Rank: 10 (near median its 10-year median of 10.00)
  • GF Value™: kr264.73 vs. price of kr244.00 (7.8% below fair value)
  • GF Score™: 99/100 with 4 warning signs

No single metric tells the full story. See the LTS:0OCD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medistim ASA Business Description

Address Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.
99GF Score

Get the complete analysis for LTS:0OCD

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr244.00
Price
kr264.73
GF Value